Profile data is unavailable for this security.
About the company
Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
- Revenue in SEK (TTM)21.34bn
- Net income in SEK260.58m
- Incorporated2016
- Employees45.00k
- LocationMedicover ABRiddargatan 12 A 3TrSTOCKHOLM 114 35SwedenSWE
- Phone+46 840017600
- Websitehttps://www.medicover.com/
Mergers & acquisitions
| Acquired company | MCOV B:STO since announced | Transaction value |
|---|---|---|
| IFLb Laboratoriumsmedizin Berlin GmbH | 23.13% | -- |
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Sep 2023 | 13.52m | 18.53% |
| AMF Fonder ABas of 30 Jun 2023 | 7.16m | 9.81% |
| SEB Investment Management ABas of 28 Mar 2024 | 2.44m | 3.35% |
| Lannebo Fonder ABas of 30 Sep 2023 | 2.35m | 3.23% |
| Mertzig Asset Management ABas of 30 Sep 2023 | 1.81m | 2.48% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.74m | 2.39% |
| SEB Investment Management AB (Denmark)as of 28 Mar 2024 | 1.60m | 2.19% |
| E. �hman J :or Fonder ABas of 31 Mar 2024 | 1.48m | 2.03% |
| Norges Bank Investment Managementas of 30 Sep 2023 | 1.47m | 2.01% |
| Enter Fonder ABas of 30 Jun 2023 | 1.45m | 1.99% |
